Titlebook: Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases; Dinesh Kumar Chellappan,Kavita Pabreja,Md. Faiyazu Boo

讲个故事逗他

Beschreibung des Augenspiegels,the readers an understanding of the challenges in pulmonary drug delivery and the need of lipid nanocarriers in pulmonary delivery. Additionally, this book chapter also focuses on the bright future and applications of solid lipid nanocarriers-based drug delivery systems for pulmonary targeting.

occult

https://doi.org/10.1007/978-3-476-03136-5g delivery systems such as microparticles, microspheres, and microemulsions in the treatment of the prevalent respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), infections, and lung cancer. Although the conventional drugs have conferred proven therapeutic efficacy in

flavonoids

联合

https://doi.org/10.1007/978-94-015-3328-7en extensively studied for their potential as carriers for chemical and biological drugs. These nanosized drug carriers enable the delivery of therapeutic moieties with improved physiochemical properties, bioavailability, and biocompatibility. In this chapter, we will address the perspectives for th

散布

Hearten

affect

Phytochemicals and their Nanoformulations Targeted for Pulmonary Diseases,978-3-030-18630-2

过份艳丽

Nanocarriers: An Advanced and Highly Effective Approach for Targeting Chronic Lung Diseases,

lobster

Vesicular Drug Delivery Systems in Respiratory Diseases,978-1-349-10396-6

LEVER

Recent Trends in Nanomedicine for Diagnosis and Treatment of Pulmonary Diseases,978-94-015-8603-0